Stay updated on Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.

Latest updates to the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page footer revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor ClinicalTrials.gov site release.SummaryDifference0.1%

- Check18 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe condition name was changed from 'Neuroendocrine pancreatic tumor' to 'Neuroendocrine tumor of pancreas' in the study's conditions section.SummaryDifference0.1%

- Check47 days agoChange DetectedCarcinoid tumor keyword added and page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.4.3 is displayed and Revision: v3.4.2 has been removed.SummaryDifference0.1%

- Check83 days agoChange DetectedThe only changes are revision labels added/removed at the bottom of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.